{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:58:15Z","timestamp":1783979895237,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0551-0","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T18:43:30Z","timestamp":1448304210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-8520","authenticated-orcid":false,"given":"Nikola","family":"Cihoric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Tsikkinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coya","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inti","family":"Zlobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"L\u00f6ssl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"issue":"15","key":"551_CR1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","volume":"340","author":"PG Rose","year":"1999","unstructured":"Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144\u201353.","journal-title":"N Engl J Med"},{"issue":"15","key":"551_CR2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","volume":"340","author":"M Morris","year":"1999","unstructured":"Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137\u201343.","journal-title":"N Engl J Med"},{"issue":"15","key":"551_CR3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401503","volume":"340","author":"HM Keys","year":"1999","unstructured":"Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs 3rd CL, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154\u201361.","journal-title":"N Engl J Med"},{"issue":"9284","key":"551_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","volume":"358","author":"JA Green","year":"2001","unstructured":"Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358(9284):781\u20136.","journal-title":"Lancet"},{"issue":"5","key":"551_CR5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.ijrobp.2009.04.009","volume":"76","author":"BM Beadle","year":"2010","unstructured":"Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ. Patterns of regional recurrence after definitive radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2010;76(5):1396\u2013403.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"551_CR6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","volume":"77","author":"EA Kidd","year":"2010","unstructured":"Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutic S, Mutch DG, et al. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2010;77(4):1085\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"551_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(08)70098-6","volume":"9","author":"L Veldeman","year":"2008","unstructured":"Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol. 2008;9(4):367\u201375.","journal-title":"Lancet Oncol"},{"issue":"3","key":"551_CR8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","volume":"87","author":"AK Gandhi","year":"2013","unstructured":"Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, et al. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys. 2013;87(3):542\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"551_CR9","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Cervical Cancer [ http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf ] Accessed date 15 Dec 2014."},{"issue":"1","key":"551_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijrobp.2008.03.064","volume":"73","author":"BM Beadle","year":"2009","unstructured":"Beadle BM, Jhingran A, Salehpour M, Sam M, Iyer RB, Eifel PJ. Cervix regression and motion during the course of external beam chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 2009;73(1):235\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"551_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1748-717X-9-83","volume":"9","author":"N Cihoric","year":"2014","unstructured":"Cihoric N, Tapia C, Kruger K, Aebersold DM, Klaeser B, Lossl K. IMRT with (1)(8)FDG-PET\\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiat Oncol. 2014;9:83.","journal-title":"Radiat Oncol"},{"issue":"1","key":"551_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijrobp.2005.01.036","volume":"62","author":"R Potter","year":"2005","unstructured":"Potter R, Dimopoulos J, Kirisits C, Lang S, Haie-Meder C, Briot E, et al. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160\u20131172). Int J Radiat Oncol Biol Phys. 2005;62(1):293\u20135. author reply 295\u2013296.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"551_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","volume":"48","author":"S Nag","year":"2000","unstructured":"Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48(1):201\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"551_CR14","doi-asserted-by":"crossref","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC). Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis. Cochrane Database of Systematic Reviews. 2010;(1):CD008285. doi: 10.1002\/14651858 .","DOI":"10.1002\/14651858"},{"issue":"5","key":"551_CR15","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","volume":"48","author":"JC Roeske","year":"2000","unstructured":"Roeske JC, Lujan A, Rotmensch J, Waggoner SE, Yamada D, Mundt AJ. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2000;48(5):1613\u201321.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"551_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-1-13","volume":"1","author":"P Chan","year":"2006","unstructured":"Chan P, Yeo I, Perkins G, Fyles A, Milosevic M. Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study. Radiat Oncol. 2006;1:13.","journal-title":"Radiat Oncol"},{"issue":"1","key":"551_CR17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0360-3016(01)01664-9","volume":"51","author":"L Portelance","year":"2001","unstructured":"Portelance L, Chao KS, Grigsby PW, Bennet H, Low D. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 2001;51(1):261\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"551_CR18","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/srao.2002.32471","volume":"12","author":"BD Kavanagh","year":"2002","unstructured":"Kavanagh BD, Schefter TE, Wu Q, Tong S, Newman F, Arnfield M, et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol. 2002;12(3):260\u201371.","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"551_CR19","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ijrobp.2008.02.063","volume":"72","author":"J Esthappan","year":"2008","unstructured":"Esthappan J, Chaudhari S, Santanam L, Mutic S, Olsen J, Macdonald DM, et al. Prospective clinical trial of positron emission tomography\/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys. 2008;72(4):1134\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"551_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2004.03.035","volume":"60","author":"RS Ahmed","year":"2004","unstructured":"Ahmed RS, Kim RY, Duan J, Meleth S, De Los Santos JF, Fiveash JB. IMRT dose escalation for positive para-aortic lymph nodes in patients with locally advanced cervical cancer while reducing dose to bone marrow and other organs at risk. Int J Radiat Oncol Biol Phys. 2004;60(2):505\u201312.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"551_CR21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ijrobp.2006.02.041","volume":"65","author":"JK Salama","year":"2006","unstructured":"Salama JK, Mundt AJ, Roeske J, Mehta N. Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2006;65(4):1170\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"551_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2006.12.023","volume":"68","author":"S Beriwal","year":"2007","unstructured":"Beriwal S, Gan GN, Heron DE, Selvaraj RN, Kim H, Lalonde R, et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2007;68(1):166\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"551_CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ygyno.2005.12.044","volume":"102","author":"K Gerszten","year":"2006","unstructured":"Gerszten K, Colonello K, Heron DE, Lalonde RJ, Fitian ID, Comerci JT, et al. Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix. Gynecol Oncol. 2006;102(2):182\u20138.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"551_CR24","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","volume":"18","author":"WA Peters 3rd","year":"2000","unstructured":"Peters 3rd WA, Liu PY, Barrett 2nd RJ, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606\u201313.","journal-title":"J Clin Oncol"},{"issue":"5","key":"551_CR25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ijrobp.2010.04.041","volume":"80","author":"MD Hasselle","year":"2011","unstructured":"Hasselle MD, Rose BS, Kochanski JD, Nath SK, Bafana R, Yashar CM, et al. Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2011;80(5):1436\u201345.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"551_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2011.03.034","volume":"122","author":"CC Chen","year":"2011","unstructured":"Chen CC, Lin JC, Jan JS, Ho SC, Wang L. Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol. 2011;122(1):9\u201313.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"551_CR27","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","volume":"52","author":"AJ Mundt","year":"2002","unstructured":"Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002;52(5):1330\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"551_CR28","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","volume":"56","author":"AJ Mundt","year":"2003","unstructured":"Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003;56(5):1354\u201360.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"551_CR29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ygyno.2011.12.432","volume":"125","author":"XL Du","year":"2012","unstructured":"Du XL, Tao J, Sheng XG, Lu CH, Yu H, Wang C, et al. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy. Gynecol Oncol. 2012;125(1):151\u20137.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"551_CR30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3802\/jgo.2014.25.1.14","volume":"25","author":"G Zhang","year":"2014","unstructured":"Zhang G, He F, Fu C, Zhang Y, Yang Q, Wang J, et al. Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer. J Gynecol Oncol. 2014;25(1):14\u201321.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"551_CR31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IGC.0b013e3182749114","volume":"23","author":"LG Jensen","year":"2013","unstructured":"Jensen LG, Hasselle MD, Rose BS, Nath SK, Hasan Y, Scanderbeg DJ, et al. Outcomes for patients with cervical cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin. Int J Gynecol Cancer. 2013;23(1):119\u201325.","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"551_CR32","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L","volume":"67","author":"FB Stehman","year":"1991","unstructured":"Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991;67(11):2776\u201385.","journal-title":"Cancer"},{"issue":"4","key":"551_CR33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/cncr.21641","volume":"106","author":"HJ Choi","year":"2006","unstructured":"Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography\/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106(4):914\u201322.","journal-title":"Cancer"},{"issue":"1","key":"551_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2007.03.027","volume":"106","author":"A Loft","year":"2007","unstructured":"Loft A, Berthelsen AK, Roed H, Ottosen C, Lundvall L, Knudsen J, et al. The diagnostic value of PET\/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol. 2007;106(1):29\u201334.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"551_CR35","first-page":"1096","volume":"278","author":"J Scheidler","year":"1997","unstructured":"Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. Jama. 1997;278(13):1096\u2013101.","journal-title":"A meta-analysis. Jama"},{"issue":"1","key":"551_CR36","first-page":"352","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Yin Y, Sheng X, Han X, Sun L, Lu C, et al. Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer. Radiat Oncol. 2015;10(1):352.","journal-title":"Radiat Oncol"},{"issue":"13","key":"551_CR37","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1200\/JCO.2009.25.9663","volume":"29","author":"A Duenas-Gonzalez","year":"2011","unstructured":"Duenas-Gonzalez A, Zarba JJ, Patel F, Alcedo JC, Beslija S, Casanova L, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678\u201385.","journal-title":"J Clin Oncol"},{"issue":"6","key":"551_CR38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","volume":"29","author":"JH Maduro","year":"2003","unstructured":"Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29(6):471\u201388.","journal-title":"Cancer Treat Rev"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0551-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:15:08Z","timestamp":1498248908000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/10\/1\/240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["551"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0551-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]},"article-number":"240"}}